Data compiled by Redley Lamar · ChainSifter Intelligence
3Suppliers
5Customers
1Debt Items
20Related Chains
Source-Backed Evidence Depth
MBX Biosciences, Inc. (MBX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
2Distinct source URLs
3High confidence
0.726Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
MBX Biosciences, Inc. Suppliers
Ticker
Name
Confidence
Evidence
INDIANA-UNIVERSITY-RESEARCH-AND-TECHNOLOGY-CORPO
INDIANA-UNIVERSITY-RESEARCH-AND-TECHNOLOGY-CORPO
92%
In the year ended December 31, 2025, the Company paid a $ 1.0 million milestone payment to IURTC related to the initiation of the Phase 1 clinical trial of MBX 4291.
Reciprocal relationship from LLY graph: Reciprocal relationship from MBX graph: Reciprocal relationship from LLY graph: Reciprocal relationship from MBX graph: Reciprocal relationship from LLY graph:…
Reciprocal relationship from SEPN graph: result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated prob…
MBX Biosciences, Inc. Customers
Ticker
Name
Confidence
Evidence
BURLINGTON-WOODS-LLC
BURLINGTON-WOODS-LLC
62%
ncome, net Interest and other income, net, which includes interest income and amortization of premiums and discounts on our investments in marketable securities, were $3.7 million for the three month…
INDIANA-UNIVERSITY-RESEARCH-AND-TECHNOLOGY-CORPO
INDIANA-UNIVERSITY-RESEARCH-AND-TECHNOLOGY-CORPO
62%
es, intellectual property and technologies; • confirm, maintain or obtain freedom to operate for any of our owned or licensed technologies and product candidates; • establish and maintain collaborati…
Reciprocal relationship from JEF graph: Reciprocal relationship from MBX graph: Reciprocal relationship from JEF graph: Reciprocal relationship from MBX graph: Reciprocal relationship from JEF graph:…
JEFFERIES-LLC
JEFFERIES-LLC
62%
FINANCIAL STATEMENTS 1. NATURE OF BUSINESS AND Liquidity MBX Biosciences, Inc. (“MBX” or the “Company”) is a clinical-stage biopharmaceutical company focused on the discovery and development of novel…
LIMITED-LIABILITY-COMPANY
LIMITED-LIABILITY-COMPANY
62%
FINANCIAL STATEMENTS 1. NATURE OF BUSINESS AND Liquidity MBX Biosciences, Inc. (“MBX” or the “Company”) is a clinical-stage biopharmaceutical company focused on the discovery and development of novel…
MBX Biosciences, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
MBX-DEBT
Debt stack $555,000
90%
Market cache reports total debt of $555,000.
MBX Biosciences, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for MBX Biosciences, Inc..
MBX Biosciences, Inc. Ownership
Holder
Name
Confidence
Evidence
MBX-OWNER-FRAZIER-LIFE-SCIENCES-MANAGEMENT
Frazier Life Sciences Management, L.P.
90%
13F overlay lists Frazier Life Sciences Management, L.P. as top holder; 159 tracked holders.
MBX Biosciences, Inc. Extended Supply Chain Network
